About: United States v. Glaxo Group Ltd.

An Entity of Type: unit of work, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

United States v. Glaxo Group Ltd., 410 U.S. 52 (1973), is a 1973 decision of the United States Supreme Court in which the Court held that (1) when a patent is directly involved in an antitrust violation, the Government may challenge the validity of the patent; and (2) ordinarily, in patent-antitrust cases, "[m]andatory selling on specified terms and compulsory patent licensing at reasonable charges are recognized antitrust remedies."

Property	Value
dbo:abstract	United States v. Glaxo Group Ltd., 410 U.S. 52 (1973), is a 1973 decision of the United States Supreme Court in which the Court held that (1) when a patent is directly involved in an antitrust violation, the Government may challenge the validity of the patent; and (2) ordinarily, in patent-antitrust cases, "[m]andatory selling on specified terms and compulsory patent licensing at reasonable charges are recognized antitrust remedies." (en)
dbo:thumbnail	wiki-commons:Special:FilePath/Justice_White_Official.jpg?width=300
dbo:wikiPageExternalLink	https://www.oyez.org/cases/1972/71-666 https://law.justia.com/cases/federal/district-courts/FSupp/328/709/1428190/ http://caselaw.lp.findlaw.com/cgi-bin/getcase.pl%3Fcourt=US&vol=410&invol=52 http://supreme.justia.com/us/410/52/case.html http://cdn.loc.gov/service/ll/usrep/usrep410/usrep410052/usrep410052.pdf
dbo:wikiPageID	20316461 (xsd:integer)
dbo:wikiPageLength	8407 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1102284022 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Potter_Stewart dbr:Patent_pool dbc:1973_in_United_States_case_law dbc:GSK_plc_litigation dbr:United_States_Department_of_Justice dbr:United_States_Department_of_Justice_Antitrust_Division dbc:United_States_Supreme_Court_cases dbr:GlaxoSmithKline dbr:Bloomberg_BNA dbr:Cross-licensing dbr:Patent dbc:United_States_antitrust_case_law dbr:Byron_White dbr:CCH_(company) dbr:William_Rehnquist dbr:Griseofulvin dbr:Harry_Blackmun dbc:United_States_patent_case_law dbc:Legal_doctrines_and_principles dbc:United_States_Supreme_Court_cases_of_the_Burger_Court dbr:L._Ed._2d dbr:Supreme_Court_of_the_United_States dbr:Test_case dbr:D.D.C. dbr:Imperial_Chemical_Industries dbc:Standing_(law) dbr:United_States_Patents_Quarterly dbr:Antitrust dbr:Sherman_Act dbr:F._Supp. dbr:U.S._LEXIS dbr:File:Justice_White_Official.jpg
dbp:arguedate	0001-11-09 (xsd:gMonthDay)
dbp:argueyear	1972 (xsd:integer)
dbp:case	United States v. Glaxo Group Ltd., (en)
dbp:decidedate	0001-01-22 (xsd:gMonthDay)
dbp:decideyear	1973 (xsd:integer)
dbp:dissent	Rehnquist (en)
dbp:findlaw	http://caselaw.lp.findlaw.com/cgi-bin/getcase.pl%3Fcourt=US&vol=410&invol=52
dbp:fullname	United States v. Glaxo Group Ltd. (en)
dbp:holding	When a patent is directly involved in an antitrust violation, the Government may challenge the validity of the patent. (en)
dbp:joindissent	Stewart and Blackmun (en)
dbp:joinmajority	Burger, Douglas, Brennan, Marshall, Powell (en)
dbp:justia	http://supreme.justia.com/us/410/52/case.html
dbp:lawsapplied	dbr:Sherman_Act
dbp:litigants	United States v. Glaxo Group Ltd. (en)
dbp:loc	http://cdn.loc.gov/service/ll/usrep/usrep410/usrep410052/usrep410052.pdf
dbp:majority	White (en)
dbp:oyez	https://www.oyez.org/cases/1972/71-666
dbp:parallelcitations	172800.0
dbp:prior	328 (xsd:integer)
dbp:uspage	52 (xsd:integer)
dbp:usvol	410 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Caselaw_source dbt:Infobox_SCOTUS_case dbt:Reflist dbt:Ussc dbt:BBstyle
dcterms:subject	dbc:1973_in_United_States_case_law dbc:GSK_plc_litigation dbc:United_States_Supreme_Court_cases dbc:United_States_antitrust_case_law dbc:United_States_patent_case_law dbc:Legal_doctrines_and_principles dbc:United_States_Supreme_Court_cases_of_the_Burger_Court dbc:Standing_(law)
rdf:type	owl:Thing dbo:Case dbo:LegalCase dbo:UnitOfWork wikidata:Q2334719 yago:WikicatUnitedStatesSupremeCourtCases yago:Abstraction100002137 yago:Case107308889 yago:Event100029378 yago:Happening107283608 yago:PsychologicalFeature100023100 yago:YagoPermanentlyLocatedEntity dbo:SupremeCourtOfTheUnitedStatesCase
rdfs:comment	United States v. Glaxo Group Ltd., 410 U.S. 52 (1973), is a 1973 decision of the United States Supreme Court in which the Court held that (1) when a patent is directly involved in an antitrust violation, the Government may challenge the validity of the patent; and (2) ordinarily, in patent-antitrust cases, "[m]andatory selling on specified terms and compulsory patent licensing at reasonable charges are recognized antitrust remedies." (en)
rdfs:label	United States v. Glaxo Group Ltd. (en)
owl:sameAs	freebase:United States v. Glaxo Group Ltd. yago-res:United States v. Glaxo Group Ltd. wikidata:United States v. Glaxo Group Ltd. https://global.dbpedia.org/id/4wsLf
prov:wasDerivedFrom	wikipedia-en:United_States_v._Glaxo_Group_Ltd.?oldid=1102284022&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Justice_White_Official.jpg
foaf:isPrimaryTopicOf	wikipedia-en:United_States_v._Glaxo_Group_Ltd.
foaf:name	(en) United States v. Glaxo Group Ltd. (en)
is dbo:wikiPageRedirects of	dbr:410_U.S._52 dbr:United_States_v._Glaxo_Group_Ltd dbr:United_States_v_Glaxo_Group_Ltd.
is dbo:wikiPageWikiLink of	dbr:List_of_United_States_Supreme_Court_patent_case_law dbr:List_of_United_States_patent_law_cases dbr:Patent_pool dbr:List_of_United_States_Supreme_Court_cases_by_the_Burger_Court dbr:United_States_antitrust_law dbr:United_States_v._American_Bell_Telephone_Co. dbr:List_of_patent_attorneys_and_agents dbr:GSK_plc dbr:410_U.S._52 dbr:Hartford-Empire_Co._v._United_States dbr:Bulk-sale_restriction dbr:United_States_v._Glaxo_Group_Ltd dbr:United_States_v_Glaxo_Group_Ltd.
is foaf:primaryTopic of	wikipedia-en:United_States_v._Glaxo_Group_Ltd.